RPG Life Sciences Ltd. is currently underperforming compared to its peers in terms of growth and profitability metrics. The company exhibits no revenue growth or profitability ratios, making it a financially weak candidate in the pharmaceuticals sector. In contrast, companies like Cipla and Dr. Reddy's Laboratories show strong financial health and growth potential, positioning them as sector leaders.

• • RPG Life Sciences has no revenue or profit growth, reflecting weak performance.
• • Cipla and Dr. Reddy's Laboratories are highlighted for their strong profitability and growth metrics.
• • Sun Pharmaceutical and Divi's Laboratories are deemed overvalued based on their PE ratios despite strong growth.